Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
1
25%
Ph phase_2
1
25%
Ph not_applicable
2
50%

Phase Distribution

1

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 2Efficacy & side effects
1(25.0%)
N/ANon-phased studies
2(50.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(3)
Other(1)

Detailed Status

Completed3
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 11 (25.0%)
Phase 21 (25.0%)
N/A2 (50.0%)

Trials by Status

unknown125%
completed375%

Recent Activity

0 active trials
Showing 4 of 4
completednot_applicable

Evaluate the Clinical Effectiveness of RegenKit Platelet-rich Plasma (PRP) in Androgenetic Alopecia Treatment

NCT02591355
unknownnot_applicable

Impact of Iron Injection on Blood Donation

NCT03014921
completedphase_2

Autologous Myoblast Intrasphincteric Injection for Fecal Incontinence

NCT01523522
completedphase_1

Paralysis of the Orbicularis Muscle of the Eye in the Treatment for Dry Eye

NCT02403219

Clinical Trials (4)

Showing 4 of 4 trials
NCT02591355Not Applicable

Evaluate the Clinical Effectiveness of RegenKit Platelet-rich Plasma (PRP) in Androgenetic Alopecia Treatment

Completed
NCT03014921Not Applicable

Impact of Iron Injection on Blood Donation

Unknown
NCT01523522Phase 2

Autologous Myoblast Intrasphincteric Injection for Fecal Incontinence

Completed
NCT02403219Phase 1

Paralysis of the Orbicularis Muscle of the Eye in the Treatment for Dry Eye

Completed

All 4 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
4